Tejnaksh Healthcare Ltd

Tejnaksh Healthcare Ltd share price declined by 1.25% to Rs 14.2 after the company's net profit tumbled by 25.71% to Rs 0.26 crore, while revenue from operations improved marginally 3.92% to Rs 2.65 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73454.32 crore, rising 9.56%. It has marginally improved by 2.51% over last one week and jumped by 15.08% in last one month while the market capitalization of Tejnaksh Healthcare Ltd has inched up 7.93% and 5.56% in the same period respectively. Profit before tax (PBT) of Tejnaksh Healthcare Ltd stood at Rs 0.42 crore in Q2 FY26, expanding by 44.83% year-on-year, and crashing by 19.23% quarter-on-quarter. EBITDA came in at Rs 1 crore, surging by 15.69% YoY and easing 3.51% sequentially. Total expenses posted a minor rise of 5.45% to Rs 2.32 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 0.0 crore, plunging by 100% YoY, while employee benefits expense was at Rs 0.29 crore, seeing a marginal contraction of 6.45% YoY. For the TTM ended FY26, revenue from operations tick up 5.91% to Rs 12.9 crore, while net profit soared by 26.70% to Rs 2.23 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 231% to Rs 3.67 crore, and PBT soared 34.03% to Rs 3.19 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 0.38 crore in FY26, as against Rs 4.01 crore in FY25. Tejnaksh Healthcare Ltd plunged by 23.88% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.83% during the same period.

Tejnaksh Healthcare Limited will hold a board meeting on August 13, 2026, to approve unaudited financial results for the quarter ended June 30, 2026, and to consider the reappointment of Mr. Suhas Vasantrao Thorat as an independent director for a second term, subject to shareholder approval. The company also previously closed its trading window for insider trading purposes, beginning June 25, 2026, and it will remain closed until 48 hours after the financial results are declared.

Net profit of Tejnaksh Healthcare declined 29.41% to Rs 0.36 crore in the quarter ended March 2026 as against Rs 0.51 crore during the previous quarter ended March 2025. Sales declined 20.56% to Rs 2.55 crore in the quarter ended March 2026 as against Rs 3.21 crore during the previous quarter ended March 2025. For the full year,net profit declined 47.21% to Rs 1.23 crore in the year ended March 2026 as against Rs 2.33 crore during the previous year ended March 2025. Sales declined 16.36% to Rs 10.79 crore in the year ended March 2026 as against Rs 12.90 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2.553.21 -21 10.7912.90 -16 OPM %27.8422.12 -25.7631.63 - PBDT0.880.77 14 3.074.10 -25 PBT0.520.59 -12 1.653.19 -48 NP0.360.51 -29 1.232.33 -47 Powered by Capital Market - Live

Net profit of Tejnaksh Healthcare declined 33.33% to Rs 0.50 crore in the quarter ended March 2026 as against Rs 0.75 crore during the previous quarter ended March 2025. Sales declined 26.25% to Rs 1.77 crore in the quarter ended March 2026 as against Rs 2.40 crore during the previous quarter ended March 2025. For the full year,net profit declined 47.33% to Rs 1.38 crore in the year ended March 2026 as against Rs 2.62 crore during the previous year ended March 2025. Sales declined 18.52% to Rs 7.17 crore in the year ended March 2026 as against Rs 8.80 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1.772.40 -26 7.178.80 -19 OPM %45.2048.33 -39.6150.91 - PBDT0.941.18 -20 3.094.45 -31 PBT0.611.03 -41 1.783.66 -51 NP0.500.75 -33 1.382.62 -47 Powered by Capital Market - Live

Tejnaksh Healthcare will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Tejnaksh Healthcare will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live

Net profit of Tejnaksh Healthcare declined 50.00% to Rs 0.31 crore in the quarter ended September 2025 as against Rs 0.62 crore during the previous quarter ended September 2024. Sales declined 11.57% to Rs 2.98 crore in the quarter ended September 2025 as against Rs 3.37 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales2.983.37 -12 OPM %26.1734.12 - PBDT0.831.14 -27 PBT0.490.83 -41 NP0.310.62 -50 Powered by Capital Market - Live

Tejnaksh Healthcare will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live

Tejnaksh Healthcare announced that the Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live

Net profit of Tejnaksh Healthcare declined 58.33% to Rs 0.25 crore in the quarter ended June 2025 as against Rs 0.60 crore during the previous quarter ended June 2024. Sales declined 15.38% to Rs 2.64 crore in the quarter ended June 2025 as against Rs 3.12 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales2.643.12 -15 OPM %23.1134.62 - PBDT0.641.03 -38 PBT0.290.80 -64 NP0.250.60 -58 Powered by Capital Market - Live